Upal Basu Roy

Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists

Kathryn F. Mileham, Caroline Schenkel, Suanna S. Bruinooge et al. · Cancer Medicine · 2021 · 51 citations · Full text

Medicine, Oncology, Medical Oncology +14

Preventing Infusion-Related Reactions With Intravenous Amivantamab—Results From SKIPPirr, a Phase 2 Study: A Brief Report

Alexander I. Spira, Luis Paz‐Ares, Ji‐Youn Han et al. · Journal of Thoracic Oncology · 2025 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer

Adam H. Fox, James R. Jett, Upal Basu Roy et al. · CHEST Journal · 2021 · 30 citations · Full text

Medicine, Molecular Medicine, Oncology +13

Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable

Edward S. Kim, Upal Basu Roy, Jennifer L. Ersek et al. · Journal of Thoracic Oncology · 2019 · 22 citations

Medicine, Molecular Medicine, Oncology +14